Carlayne Jackson, MD
Basic profileThe University of Texas at San Antonio Health Science Center
Carlayne Jackson is a Neurology physician affiliated with The University of Texas at San Antonio Health Science Center. OpenAlex indexes 170 publications with 10,064 citations (h-index 45); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients With Amyotrophic Lateral Sclerosis (ALS)
Sponsor: The University of Texas Health Science Center at San Antonio
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
NIH funding
1 NIH research award on record, funded 1997–2008 per NIH RePORTER. The latest:
- EARLY TX OF ALS WITH NUTRITION AND NON-INVASIVE POSITIVE PRESSURE VENTILATION
University of Texas Hlth Science Center
FY2008$1,215M01RR001346 - CLINICAL TRIAL: CLINICAL TRIAL OF HIGH DOSE COQ10 IN ALS
University of Texas Hlth Science Center
FY2008$868M01RR001346 - EARLY TX OF ALS WITH NUTRITION AND NON-INVASIVE POSITIVE PRESSURE VENTILATION
University of Texas Hlth Science Center
FY2007$29,923M01RR001346
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial
Journal of Neurology Neurosurgery & Psychiatry
2022 - Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis
New England Journal of Medicine
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Dean Kellogg, MD
The University of Texas at San Antonio Health Science Center
Marcos Restrepo, MD, MSc
The University of Texas at San Antonio Health Science Center
Robert Brzyski, MD
The University of Texas at San Antonio Health Science Center
Devjit Tripathy, MD
The University of Texas at San Antonio Health Science Center
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”